Product
Atropine Ophthalmic
2 clinical trials
2 indications
Indication
vitreous floatersIndication
MyopiaClinical trial
Low Dose Atropine For Symptomatic Vitreous FloatersStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Clinical trial
Investigator Led, Double-masked, Multicenter, Randomized Clinical Trial for the Comparison of Atropine 0.5% Versus Atropine 0.05% Eye Drops for the Prevention of Myopia Progression in Dutch ChildrenStatus: Recruiting, Estimated PCD: 2028-12-01